Financial Results for the quarter and three months period ended 30th June 2026.

Date: 12-08-2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G Listing Department Bandra Kurla Complex, Dalal Street, Bandra East, Mumbai-400051 Mumbai-400001 Scrip Code: MUKKA Scrip Code: 544135 Dear Sir/Madam, Subject: Outcome of the Board Meeting held on 12th August 2026. Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (including any statutory modification(s), amendment(s) or re-enactment(s) thereof for the time being in force), this is to inform you that the Board of Directors of the Company (“Board) at their meeting held today i.e. Wednesday, 12th August 2026, have inter-alia considered and approved the following business: 1. Financial Results: The unaudited financial results (standalone and consolidated) of the Company for the quarter and three months period ended 30th June 2026. The same is enclosed. Further, the Limited Review Report received from the Statutory Auditors of the Company is also enclosed. 2. The 16th Annual General Meeting (AGM) of the Company will be held on Thursday, 10th September 2026 at 3:00 p.m. through Video Conferencing/Other Audio-Visual Means (“VC/OAVM”) facility. 3. Cancellation and withdrawal of the proposed issuance of Non-Convertible Debentures on Private Placement Basis The Board has approved the cancellation and withdrawal of the proposed issuance of Senior, Secured, Rated, Listed, Redeemable, Taxable, Transferable, INR Denominated Non-Convertible Debentures aggregating up to ₹75,00,00,000/- (Rupees Seventy-Five Crore Only) on a private placement basis. 4. To invest in Swachha Eco Solutions Private Limited (SESPL): The Board has approved to make investment in SESPL and to make a capital contribution of Rs. 64,92,500/- (Rupees Sixty- Four Lakh Ninety-Two Thousand Five Hundred Only) representing 25.98% of the capital, thereby making SESPL an associate of the Company. 5. Re-appointment of Mr. Karkala Shankar Balachandra Rao (DIN: 03589394) as a Non- Executive Independent Director of the Company: Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the re-appointment of Mr. Karkala Shankar Balachandra Rao (DIN: 03589394) as a Non-Executive Independent Director of the Company for a second term of five (5) consecutive years, commencing from 15th January 2027 to 14th January 2032 (both days inclusive), subject to the approval of the Shareholders by way of a Special Resolution. 6. Re-appointment of Mr. Hamad Bava (DIN: 09448423) as a Non-Executive Independent Director of the Company: Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the re-appointment of Mr. Hamad Bava (DIN: 09448423) as a Non-Executive Independent Director of the Company for a second term of five (5) consecutive years, commencing from 15th January 2027 to 14th January 2032 (both days inclusive), subject to the approval of the Shareholders by way of a Special Resolution. 7. Re-appointment of Mr. Narendra Surendra Kamath (DIN: 07255904) as a Non-Executive Independent Director of the Company: Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the re-appointment of Mr. Narendra Surendra Kamath (DIN: 07255904) as a Non-Executive Independent Director of the Company for a second term of five (5) consecutive years, commencing from 15th January 2027 to 14th January 2032 (both days inclusive), subject to the approval of the Shareholders by way of a Special Resolution. 8. Re-appointment of Mr. Kalandan Mohammed Haris (DIN: 03020471) as Managing Director and Chief Executive Officer of the Company: Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the re-appointment of Mr. Kalandan Mohammed Haris (DIN: 03020471) as Managing Director and Chief Executive Officer of the Company for a further period of five (5) years, commencing from 20th January 2027 to 19th January 2032 (both days inclusive), subject to the approval of the Shareholders by way of a Special Resolution. 9. Re-appointment of Mr. Kalandan Mohammed Althaf (DIN:03051103) as Whole-Time Director and Chief Financial Officer of the Company: Based on the recommendation of the Nomination and Remuneration Committee ("NRC"), the Board has approved the re-appointment of Mr. Kalandan Mohammed Althaf (DIN:03051103) as Whole-Time Director and Chief Financial Officer of the Company for a further period of five (5) years, commencing from 20th January 2027 to 19th January 2032 (both days inclusive), subject to the approval of the Shareholders by way of a Special Resolution. 10. To recommend the re-appointment of Mr. Kalandan Mohammad Arif (DIN:03020564) as Whole-Time Director and Chief Operating Officer of the Company: Based on the recommendation of the Nomination and Remuneration Committee, the Board has approved the re-appointment of Mr. Kalandan Mohammad Arif (DIN:03020564) as Whole-Time Director and Chief Operating Officer of the Company for a further period of five (5) years, commencing from 20th January 2027 to 19th January 2032 (both days inclusive), subject to the approval of the Shareholders by way of a Special Resolution. The detailed disclosure as required under SEBI Circular No. SEBI/HO/CFD/CFDPoD1/P/CIR/2023/123 dated July 13, 2023 and such other circulars as applicable, in respect of Sl. No. 4 to 10 is enclosed as Annexure I to III. The Meeting commenced at 03:30 p.m. and concluded at 4:15 p.m. This is for your information and records. Thank you, For Mukka Proteins Limited Mehaboobsab Mahmadgous Chalyal Company Secretary & Compliance Officer Membership No.: A67502 Encl: as above. SHAH & TAPARIA CHARTERED ACCOUNTANTS 203, Center Point Building, 100, Dr. Babasaheb Ambedkar Road, Opp. Bharatmata Theater, Lalbaug, Parel, Mumbai - 400 012. Tel.: 022 - 42116800 Fax :; 022-4022 0314 E-mail : Info@shahtaparia.com Visit us at : www.shahtaparia.com Independent Auditor’s Review Report on Quarterly and Year to Date Unaudited Consolidated Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended The Board of Directors Mukka Proteins Limited We have reviewed the accompanying Statement of Unaudited Consolidated Financial Results of Mukka Proteins Limited (“the Parent”), its subsidiaries (the Parent and its subsidiaries together referred to as “the Group”) and Group’s share of the net profit/loss after tax and total comprehensive income/loss of its joint ventures, for the quarter ended June 30, 2026 (the Statement’) attached herein, being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This Statement, which is the responsibility of the Parent’s Management and approved by the ‘Parent’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “{nterim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 “Review of Interim Financial Information Performed by the Independent Auditor of the Entity”, issued by the Institute of Chartered Accountants of India (ICAI). A review of interim financial information consists of making inquiries, primarily of Parent’s personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under Section 143(10) of the Companies Act, 2 [Showing first 8,000 characters — download PDF for full document]